AzTrials
AzTrials

Traumatic Brain Injury With Prolonged Loss of ConsciousnessAWAKENCT03998930

Evaluation of Consciousness by Brain-computer Interface in Severely Brain Damaged Patients

A study testing Clinical evaluation of consciousness by the Coma Recovery Scale Revised (CRS-R) in people with Traumatic Brain Injury With Prolonged Loss of Consciousness and Stroke, run by Centre Hospitalier Universitaire de Nīmes at 4 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objective of this study is to show that the measurement of auditory and vibro-tactile evoked potentials, or the recording of the EEG signal during a motor imaging task, can be used in routine clinical situations to explore the state of consciousness of subjects in Non-responsive Awakening (or Chronic Vegetative… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Clinical evaluation of consciousness by the Coma Recovery Scale Revised (CRS-R)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
9 participants
Where
4 sitesFrance
Study dates
6 Mar 2018to 21 Aug 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • The patient and/or his/her trusted person, relative or legal representative must have given free and informed consent and signed the consent
  • The patient must be a member or beneficiary of a health insurance plan
  • The patient is available for a 10-day follow-up
  • Women and men are included
  • The patient is at least 18 years old
  • Subjects with conscious disorder, non-respondents after traumatic brain injury (head injury) or non-traumatic brain injury (hemorrhagic and/or ischemic stroke, cerebral anoxia, encephalitis).

Who cannot join

  • Subject is participating in another intervention study
  • The subject is in an exclusion period determined by a previous study
  • The subject or his or her trusted person, relative or legal representative refuses to sign the consent
  • The patient is pregnant or breastfeeding
  • The subject has hemodynamic, respiratory and/or neurological instability
  • The subject has an ENT infection in the ears (wearing headphones)
  • History of auditory and/or sensory sensory impairment
  • Psychiatric history (other than anxiety-depressive syndrome)

Trial locations and contacts

4 sites in 1 country.

France4 sites
  • CHU de Montpellier

    Montpellier, 34000

  • Clinique Fontfroide

    Montpellier, 34097

  • CHU de Nîmes

    Nîmes, 30129

  • Hôpital d'Uzès

    Uzès, 30701

Other trials in France

About this study

Official title: Brain-computer Interface in the Diagnosis of Disorders of Consciousness

The objective of this study is to show that the measurement of auditory and vibro-tactile evoked potentials, or the recording of the EEG signal during a motor imaging task, can be used in routine clinical situations to explore the state of consciousness of subjects in Non-responsive Awakening (or Chronic Vegetative State) or in Minimal Consciousness (or relational state) after a severe brain injury.

Assumptions :

  • Correlation between patient response rates obtained with the brain-machine interface and their clinical consciousness score (Coma Recovery Scale Revised score)
  • Differentiation of the parameters of the evoked potentials P300 between patients in a vegetative state and those in a state of minimal consciousness
Read the detailed description

this is a pilot study on information obtained using a medical device marketed in accordance with CE standards, multicentric and prospective.

The study participation consists of five assessments of the subjects' level of awareness. Each evaluation lasts a total of two hours.

Patients will be assessed in their rooms as follows:

  • Clinical evaluation of consciousness by the Coma Recovery Scale Revised (CRS-R), a clinical scale considered as the "gold-standard". Duration 45 minutes (standard care in routine care)
  • 15-minute break between the two evaluations.
  • Paraclinical evaluation of consciousness by the brain-machine interface by measuring evoked potentials P300 auditory and vibrotactile and recording the EEG signal during a motor imaging task (imagine moving the right or left wrist). Duration 60 minutes.

Instructions are given to the subject via headphones, in French. For the analysis of the evoked potentials, vibrotactile stimuli are delivered to the wrists and ankle of the subject. For auditory evoked potentials, auditory stimuli are delivered by headphones. The volume can be changed.

These assessments that we will perform with the brain-machine interface are similar to the assessments and stimulation of awakening and awareness sessions performed by speech-language pathologists in the departments concerned (presentation of visual and auditory stimuli). CRS-R is used in routine care to assess patients' level of consciousness. There is no recommendation on the type of additional examination to be performed (neuroimaging, EEG, evoked potentials) or on their frequency for the evaluation of patients' consciousness at a distance from their initial brain injury.

Evaluation by the brain-machine interface in the room makes it possible to avoid transport to the complementary examination services (Medical Imaging Services, Neurological Functional Explorations) which cause fatigue (patient whose vigilance is fluctuating) which can make the complementary examination non-contributory. Patients are also not assessed at a date and time set by a complementary examination service and room assessment allows the patient to be assessed in the best conditions for him/her when he/she appears to be at his/her highest level of consciousness and rested (after consultation with the family and/or healthcare team).

Total duration of each session of a maximum of 2 hours, including the installation and uninstallation of the brain-machine interface.

Patients receive their usual treatment and continue to participate in rehabilitation.

Being tested
Clinical evaluation of consciousness by the Coma Recovery Scale Revised (CRS-R)
Keywords
Disorders of consciousness,, Brain Computer Interface, P300, Motor imagery
Medical subject headings
Stroke, Hypoxia, Brain, Consciousness Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Clinical evaluation of consciousness by the Coma Recovery Scale Revised (CRS-R)Other

    Also called other

    Paraclinical evaluation of consciousness by the brain-machine interface by measuring evoked potentials P300 auditory and vibrotactile and recording the EEG signal during a motor imaging task

Study groups in NCT03998930
Study groupRoleWhat they receive
brain injuried patientsExperimental* Clinical evaluation of consciousness by the Coma Recovery Scale Revised (CRS-R), * 15-minute break between the two evaluations. * Paraclinical evaluation of consciousness by the brain-machine interface by measuring evoked potentials P300 auditory and vibrotactile and recording the EEG signal during a motor imaging task (imagine moving the right or left wrist).
Receives: Other: Clinical evaluation of consciousness by the Coma Recovery Scale Revised (CRS-R)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. correlation between the response of patients obtained with the brain-machine interface (detection of auditory and vibrotactile P300 and modifications of EEG signal during a motor imagery task) and their clinical consciousness score

    correlation coefficient (units: -1; 1)

    Measured: Inclusion

  2. correlation between the response of patients obtained with the brain-machine interface (detection of auditory and vibrotactile P300 and modifications of EEG signal during a motor imagery task) and their clinical consciousness score

    correlation coefficient (units: -1; 1)

    Measured: Day 2

  3. correlation between the response of patients obtained with the brain-machine interface (detection of auditory and vibrotactile P300 and modifications of EEG signal during a motor imagery task) and their clinical consciousness score

    correlation coefficient (units: -1; 1)

    Measured: Day 4

  4. correlation between the response of patients obtained with the brain-machine interface (detection of auditory and vibrotactile P300 and modifications of EEG signal during a motor imagery task) and their clinical consciousness score

    correlation coefficient (units: -1; 1)

    Measured: Day 6

  5. correlation between the response of patients obtained with the brain-machine interface (detection of auditory and vibrotactile P300 and modifications of EEG signal during a motor imagery task) and their clinical consciousness score

    correlation coefficient (units: -1; 1)

    Measured: Day 10

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jun 2019
  2. Study start6 Mar 2018
  3. Primary completion21 Aug 2018
  4. Study completion21 Aug 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
9 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03998930
Sponsor's protocol ID
Local/2017/FF-02
Other IDs
2017-A02539-44
Acronym
AWAKE
Status last verified
Jul 2019
First submitted
25 Jun 2019
Last updated
19 Jul 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Clinical evaluation of consciousness by the Coma Recovery Scale Revised (CRS-R) in people with Traumatic Brain Injury With Prolonged Loss of Consciousness and Stroke, run by Centre Hospitalier Universitaire de Nīmes at 4 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Jul 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

correlation between the response of patients obtained with the brain-machine interface (detection of auditory and vibrotactile P300 and modifications of EEG signal during a motor imagery task) and their clinical consciousness score (time frame: Inclusion). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Jul 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in